Q3 2021 Holdings
Filed 2021-11-15 | 60 holdings | $581.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $311.7M | 4,220,048 | 53.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $121.2M | 760,606 | 20.8% |
| Aadi Bioscience Inc(WHWK) | Common | 00032Q104 | $41.9M | 1,427,213 | 7.2% |
| Celldex Therapeutics Inc(CLDX) | Common | 15117B202 | $26.2M | 484,453 | 4.5% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $16.9M | 940,754 | 2.9% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $12.0M | 1,420,941 | 2.1% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $11.1M | 500,732 | 1.9% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $10.9M | 517,280 | 1.9% |
| Arcutis Biotherapeutics Inc(ARQT) | Common | 03969K108 | $10.4M | 433,585 | 1.8% |
| Codexis, Inc(CDXS) | Common | 192005106 | $9.0M | 388,144 | 1.6% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $8.6M | 137,411 | 1.5% |
| Instil Bio Inc | Common | 45783C101 | $223.2K | 12,486,787 | 0.0% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $187.2K | 4,884,341 | 0.0% |
| New Frontier Health Corp | Ord Shs | G6461G106 | $160.6K | 14,300,000 | 0.0% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $159.8K | 11,642,195 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | Common | 46583P102 | $96.9K | 5,966,527 | 0.0% |
| Genetron Holdings Ltd | ADS | 37186H100 | $87.8K | 6,339,860 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $64.4K | 2,987,331 | 0.0% |
| Aligos Therapeutics Inc | Common | 01626L105 | $55.0K | 3,547,030 | 0.0% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $49.0K | 3,871,291 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U404 | $42.0K | 1,917,074 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Kadmon Holdings Inc(KDMN) | Common | 48283N106 | $37.3K | 4,283,014 | 0.0% |
| Impel NeuroPharma Inc | Common | 45258K109 | $35.1K | 2,884,789 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $34.1K | 1,238,575 | 0.0% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $28.8K | 2,937,093 | 0.0% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $28.7K | 1,641,913 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $27.9K | 2,675,133 | 0.0% |
| Legend Biotech Corp Sponsored(LEGN) | SPONSORED ADS | 52490G102 | $24.7K | 488,751 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $21.4K | 1,300,000 | 0.0% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $20.6K | 1,856,011 | 0.0% |
| Zai Lab Ltd ADR(ZLAB) | ADR | 98887Q104 | $18.4K | 174,999 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $16.7K | 6,907,189 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $15.1K | 2,749,918 | 0.0% |
| Nkarta Inc(NKTX) | Common | 65487U108 | $14.2K | 512,225 | 0.0% |
| Dice Therapeutics Inc | Common | 23345J104 | $13.4K | 410,000 | 0.0% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $13.3K | 961,359 | 0.0% |
| Curis Inc(CRISEUR) | Common | 231269200 | $12.2K | 1,553,500 | 0.0% |
| Chinook Therapeutics Inc(290A) | Common | 16961L106 | $11.1K | 872,151 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $9.8K | 525,262 | 0.0% |
| Merus NV | Common | N5749R100 | $9.7K | 442,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $9.4K | 577,642 | 0.0% |
| Essa Pharma Inc(EPIEUR) | Common | 29668H708 | $8.4K | 1,056,067 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $8.3K | 286,064 | 0.0% |
| Design Therapeutics(DSGN) | Common | 25056L103 | $7.8K | 530,991 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $6.7K | 853,143 | 0.0% |
| Valneva SE(VALN) | SPONSORED ADS | 92025Y103 | $6.3K | 200,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | Common | 87164F105 | $6.1K | 320,000 | 0.0% |
| Satsuma Pharmaceuticals Inc | Common | 80405P107 | $5.7K | 1,232,394 | 0.0% |
| Passage Bio Inc | Common | 702712100 | $5.4K | 539,263 | 0.0% |